Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy is a research paper published in Cardiovascular Research (2021). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research Scholarship
Grant: DGK082018
German Heart Foundation
Grant: F/15/18 to F.W.
German Heart Foundation
Grant: F/41/15 to C.S.
German Research Foundation
Grant: SCHM 3358/1-1 to C.S.
German Research Foundation
Grant: SFB 1425 to C.S.
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
FWCI
5.41
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals